By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ben Venue Laboratories 

(Acquired By Boehringer Ingelheim)
300 Northfield Ridge
Bedford  Ohio  44146  U.S.A.
Phone: 800-562-4797 Fax: 440-232-6264

Ben Venue Laboratories, Inc. was founded in 1938 and is a leading contract manufacturer of highly complex, sterile injectable drug products for the global pharmaceutical industry. Ben Venue is located in Bedford, Ohio and employs more than 1,300 people. For more information and current career opportunities, visit Ben Venue is a U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the BoehringerIngelheim group of companies.

The commitment, competence and creative power of our people, sustained for well over a century, has made BoehringerIngelheim a first-class, fast-growing pharmaceutical corporation. This is reflected at the Ben Venue Laboratories, Inc. We provide our employees demanding and challenging roles and the appropriate opportunities for development and career advancement at national and international levels, as well as performance-related total rewards.

Key Statistics

Ownership: Subsidiary

Web Site: Ben Venue Laboratories


Company News
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site 9/17/2014 10:44:16 AM
Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site 7/24/2014 6:37:28 AM
Ben Venue Laboratories Issues A Voluntary Nationwide Patient Level Recall Of Acetylcysteine Solution 10%, USP, Lot 2005479 2/17/2014 6:23:00 AM
Boehringer Ingelheim Corporation's Ben Venue Laboratories to Shut Down Operations Permanently; 1,100 Staffers Handed Pink Slips 10/4/2013 7:46:23 AM
Boehringer Mannheim Corporation's Ben Venue Laboratories to Trim Hundreds of Jobs, Will Cut Production Activity by Year's End 8/20/2013 7:13:14 AM
Ben Venue Laboratories Resumes Limited Production at Troubled Ohio Plant 10/18/2012 7:54:37 AM
European Medicines Evaluation Agency Wants Two More Drugs Moved From Ben Venue Laboratories Due to Ongoing Manufacturing Practice Concerns 3/20/2012 8:20:22 AM
Sanofi (France) (SAN.PA)'s Genzyme Corporation (GENZ) Recalls 9,380 Vials of Fludara Leukemia Drug Made at Ben Venue Laboratories Plant 2/16/2012 7:22:44 AM
Ben Venue Laboratories's Children Leukemia Drug May Run Out Within Weeks 2/13/2012 8:13:35 AM
Vion Pharmaceuticals (VION) Enters Into Manufacturing Agreement For Cloretazine(R) (VNP40101M) With Ben Venue Laboratories 12/13/2006 1:30:09 PM